{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:17:10Z","timestamp":1785421030792,"version":"3.56.0"},"reference-count":104,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009663","name":"University Health Network","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009663","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/042xt5161","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>In 2025, tropical medicine was shaped by advances in diagnostic technology, expanding arboviral epidemics, rapid progress in filovirus vaccine development, evolving regulatory responses to newly licensed vaccines, and translational breakthroughs addressing neglected tropical diseases. This review discusses five select developments that significantly influenced clinical practice and global health policy over the past year, highlighting the implications of each for clinicians, researchers, and public health systems.<\/jats:p>","DOI":"10.3390\/idr18030060","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:37:42Z","timestamp":1781879862000},"page":"60","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Five Hot Topics in Tropical Medicine: 2025"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3586-746X","authenticated-orcid":false,"given":"Amanda","family":"Hempel","sequence":"first","affiliation":[{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada"},{"name":"Tropical Disease Unit, Toronto General Hospital, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-3307","authenticated-orcid":false,"given":"Gregory D.","family":"Hawley","sequence":"additional","affiliation":[{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada"},{"name":"Tropical Disease Unit, Toronto General Hospital, University Health Network, Toronto, ON M5G 2C4, Canada"},{"name":"Institute of Medical Science, University of Toronto, Toronto, ON M5S 3H2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahmar","family":"Hewitt","sequence":"additional","affiliation":[{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada"},{"name":"Tropical Disease Unit, Toronto General Hospital, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1228-0957","authenticated-orcid":false,"given":"Maxime","family":"Billick","sequence":"additional","affiliation":[{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada"},{"name":"Tropical Disease Unit, Toronto General Hospital, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne J.","family":"Showler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada"},{"name":"Tropical Disease Unit, Toronto General Hospital, University Health Network, Toronto, ON M5G 2C4, Canada"},{"name":"Department of Medicine, Georgetown University, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Kain","sequence":"additional","affiliation":[{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada"},{"name":"Tropical Disease Unit, Toronto General Hospital, University Health Network, Toronto, ON M5G 2C4, Canada"},{"name":"Institute of Medical Science, University of Toronto, Toronto, ON M5S 3H2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2720-6944","authenticated-orcid":false,"given":"Andrea K.","family":"Boggild","sequence":"additional","affiliation":[{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada"},{"name":"Tropical Disease Unit, Toronto General Hospital, University Health Network, Toronto, ON M5G 2C4, Canada"},{"name":"Institute of Medical Science, University of Toronto, Toronto, ON M5S 3H2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2025, December 20). Malaria. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/malaria."},{"key":"ref_2","unstructured":"WHO (2025). Guidelines for Malaria, World Health Organization. Available online: https:\/\/app.magicapp.org\/#\/guideline\/LwRMXj\/section\/L0v9rE."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.53854\/liim-2903-6","article-title":"Loop-Mediated Isothermal Amplification (LAMP) Assay for the Diagnosis of Imported Malaria: A Narrative Review","volume":"29","author":"Antinori","year":"2021","journal-title":"Infez. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/bjh.18092","article-title":"for British Society for Haematology guidelines for the laboratory diagnosis of malaria","volume":"197","author":"Rogers","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_5","unstructured":"(2025, December 01). Committee to Advise on Tropical Medicine and Travel Chapter 6\u2014Malaria Diagnosis: Canadian Recommendations for the Prevention and Treatment of Malaria. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/catmat\/canadian-recommendations-prevention-treatment-malaria\/chapter-6-malaria-diagnosis.html."},{"key":"ref_6","unstructured":"Nucleic Acid Amplification-Based Diagnostics, World Health Organization. Available online: https:\/\/www.who.int\/teams\/global-malaria-programme\/case-management\/diagnosis\/nucleic-acid-amplification-based-diagnostics."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Morris, U., and Aydin-Schmidt, B. (2021). Performance and Application of Commercially Available Loop-Mediated Isothermal Amplification (LAMP) Kits in Malaria Endemic and Non-Endemic Settings. Diagnostics, 11.","DOI":"10.3390\/diagnostics11020336"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40249-025-01329-1","article-title":"Technologies for the Point-of-Care Diagnosis of Malaria: A Scoping Review","volume":"14","author":"Coro","year":"2025","journal-title":"Infect. Dis. Poverty"},{"key":"ref_9","unstructured":"Public Health Agency of Canada CATMAT (2026, June 16). Recommendations for the Use of Chikungunya Live Attenuated Vaccine (IXCHIQ). Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/catmat\/recommendations-use-chikungunya-vaccine.html."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.cmi.2025.03.008","article-title":"Kinetics of the Alethia\u00ae Malaria Loop-Mediated Isothermal Amplification (LAMP) Positivity during Post-Treatment Follow-up of Patients with Imported Malaria","volume":"31","author":"Lambert","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/23744235.2021.2023754","article-title":"The Value of Lamp to Rule out Imported Malaria Diagnosis: A Retrospective Observational Study in Milan, Italy","volume":"54","author":"Giacomelli","year":"2022","journal-title":"Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/ajcp\/aqaa173","article-title":"Malaria Screening Using Front-Line Loop-Mediated Isothermal Amplification: Fourteen-Month Experience in a Nonendemic Regional Hub-and-Spoke Laboratory Setting","volume":"155","author":"McGinnis","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1051\/parasite\/2017054","article-title":"Diagnostic Accuracy of Loop-Mediated Isothermal Amplification (LAMP) for Screening Patients with Imported Malaria in a Non-Endemic Setting","volume":"24","author":"Ponce","year":"2017","journal-title":"Parasite"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"taz052","DOI":"10.1093\/jtm\/taz052","article-title":"Added Value of Loop-Mediated Isothermal Amplification Technology (LAMP) in Real Life for the Diagnosis of Malaria in Travellers","volume":"26","author":"Burdino","year":"2019","journal-title":"J. Travel Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tmaid.2018.05.006","article-title":"Evaluation of Automated Loop-Mediated Amplification (LAMP) for Routine Malaria Detection in Blood Samples of German Travelers\u2014A Cross-Sectional Study","volume":"24","author":"Frickmann","year":"2018","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4269\/ajtmh.18-0496","article-title":"Use of Loop-Mediated Isothermal Amplification in a Resource-Saving Strategy for Primary Malaria Screening in a Non-Endemic Setting","volume":"100","author":"Hartmeyer","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"ofy260","DOI":"10.1093\/ofid\/ofy260","article-title":"Clinical Validation of a Commercial LAMP Test for Ruling out Malaria in Returning Travelers: A Prospective Diagnostic Trial","volume":"5","author":"Cheaveau","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ljolje, D., Abdallah, R., and Lucchi, N.W. (2021). Detection of Malaria Parasites in Samples from Returning US Travelers Using the Alethia\u00ae Malaria Plus LAMP Assay. BMC Res. Notes, 14.","DOI":"10.1186\/s13104-021-05542-7"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"115680","DOI":"10.1016\/j.diagmicrobio.2022.115680","article-title":"Clinical Accuracy of Malaria Loop-Mediated Isothermal Amplification Assay as a Stand-Alone Screening Tool at a Non-Endemic Northern California Regional Health System","volume":"103","author":"Costales","year":"2022","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.pathol.2022.10.010","article-title":"Verification and Implementation of a Commercial Loop-Mediated Isothermal Amplification (LAMP) Assay for Malaria Testing in a Public Laboratory in New South Wales, Australia","volume":"55","author":"Ahuja","year":"2023","journal-title":"Pathology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1387","DOI":"10.1093\/cid\/ciab221","article-title":"The Role of Ultrasensitive Molecular Methods for Detecting Malaria\u2014The Broader Perspective","volume":"73","author":"Kamaliddin","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100008","DOI":"10.1016\/j.lanprc.2025.100008","article-title":"Active Case Detection Using Loop-Mediated Isothermal Amplification Technology and Treatment versus Standard of Care for Malaria in Pregnancy in Ethiopia (LAMPREG): A Pragmatic Randomised Diagnostic Outcomes Trial","volume":"1","author":"Teferi","year":"2025","journal-title":"Lancet Prim. Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8925","DOI":"10.1038\/s41467-025-64027-4","article-title":"Sensitive near Point-of-Care Detection of Asymptomatic and Submicroscopic Plasmodium falciparum Infections in African Endemic Countries","volume":"16","author":"Pennisi","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"111529","DOI":"10.1016\/j.molbiopara.2022.111529","article-title":"Application of a Low-Cost, Specific, and Sensitive Loop-Mediated Isothermal Amplification (LAMP) Assay to Detect Plasmodium falciparum Imported from Africa","volume":"252","author":"Zhang","year":"2022","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1038\/s41598-025-92935-4","article-title":"Development of a Rapid Malaria LAMP-MS Assay for Diagnosis of Malaria Infections","volume":"15","author":"Jang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e5375","DOI":"10.21769\/BioProtoc.5375","article-title":"Rapid and Multiplex Diagnosis of Malaria Using Chelex-100 Extraction and LAMP-MS Assay","volume":"15","author":"Lim","year":"2025","journal-title":"Bio-protocol"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Myers, M.B., and Schandl, C.A. (2023). Ultrasensitive Reverse Transcriptase Loop-Mediated Isothermal Amplification (US-LAMP)-Based Detection of Malaria Infection from Dried Blood Spots. Clinical Applications of Nucleic Acid Amplification, Springer US.","DOI":"10.1007\/978-1-0716-2950-5"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1038\/s41591-024-03300-3","article-title":"Human Outbreaks of a Novel Reassortant Oropouche Virus in the Brazilian Amazon Region","volume":"30","author":"Naveca","year":"2024","journal-title":"Nat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4269\/ajtmh.16-0672","article-title":"Oropouche Virus: Clinical, Epidemiological, and Molecular Aspects of a Neglected Orthobunyavirus","volume":"96","author":"Figueiredo","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-022-00456-2","article-title":"Baseline Mapping of Oropouche Virology, Epidemiology, Therapeutics, and Vaccine Research and Development","volume":"7","author":"Files","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Bai, F., Denyoh, P.M.D., Urquhart, C., Shrestha, S., and Yee, D.A. (2025). A Comprehensive Review of the Neglected and Emerging Oropouche Virus. Viruses, 17.","DOI":"10.3390\/v17030439"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"199318","DOI":"10.1016\/j.virusres.2024.199318","article-title":"Oropouche Virus: A Neglected Global Arboviral Threat","volume":"341","author":"Zhang","year":"2024","journal-title":"Virus Res."},{"key":"ref_33","unstructured":"World Health Organization (2026, January 08). Oropouche Virus Disease. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/oropouche-virus-disease."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2439521","DOI":"10.1080\/21505594.2024.2439521","article-title":"Oropouche Virus: Understanding \u201cSloth Fever\u201d Disease Dynamics and Novel Intervention Strategies against This Emerging Neglected Tropical Disease","volume":"15","author":"Cain","year":"2024","journal-title":"Virulence"},{"key":"ref_35","unstructured":"Public Health Agency of Canada (2026, January 08). Oropouche Virus Disease: For Health Professionals. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/mosquitoes\/oropouche-virus\/health-professionals.html."},{"key":"ref_36","unstructured":"Pan American Health Organization, and World Health Organization (2025). Epidemiological Update Oropouche in the Americas Region, Pan American Health Organization."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40794-024-00236-x","article-title":"Addressing the Emerging Threat of Oropouche Virus: Implications and Public Health Responses for Healthcare Systems","volume":"11","author":"Okesanya","year":"2025","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"ref_38","first-page":"100896","article-title":"Oropouche Fever Fatalities and Vertical Transmission in South America: Implications of a Potential New Mode of Transmission","volume":"38","author":"Sah","year":"2024","journal-title":"Lancet Reg. Health Am."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMc2412812","article-title":"A Case of Vertical Transmission of Oropouche Virus in Brazil","volume":"391","author":"Maia","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3201\/eid3012.241470","article-title":"Replication-Competent Oropouche Virus in Semen of Traveler Returning to Italy from Cuba, 2024","volume":"30","author":"Castilletti","year":"2024","journal-title":"Emerg. Infect. Dis."},{"key":"ref_41","unstructured":"CDC (2026, January 08). Updated Interim Guidance for Health Departments on Testing and Reporting for Oropouche Virus Disease, Available online: https:\/\/www.cdc.gov\/oropouche\/php\/reporting\/index.html."},{"key":"ref_42","unstructured":"Secretariat of Health and Environmental Surveillance, Department of Transmissible Diseases, and General Coordination of Arbovirus Surveillance (2024). Joint Technical Note No. 135\/2024-SVSA\/SAPS\/SAES\/MS: Guidelines for Notification and Investigation of Suspected Cases of Oropouche Syndrome in Pregnant Women, Congenital Anomalies, or Fetal Deaths, Ministry of Health of Brazil."},{"key":"ref_43","first-page":"001998","article-title":"The Ebola Virus\u2014Going beyond the Bleeding Edge","volume":"74","author":"Umar","year":"2025","journal-title":"J. Med. Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of Zaire Ebola Virus Disease in Guinea","volume":"371","author":"Baize","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJMoa1511410","article-title":"Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors\u2014Final Report","volume":"377","author":"Deen","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa2024670","article-title":"Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease","volume":"384","author":"Pratt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(16)30386-5","article-title":"Late Ebola Virus Relapse Causing Meningoencephalitis: A Case Report","volume":"388","author":"Jacobs","year":"2016","journal-title":"Lancet Lond. Engl."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/cid\/ciw601","article-title":"Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor with Virus Persistence in Seminal Fluid for More Than 500 Days","volume":"63","author":"Diallo","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_49","unstructured":"WHO (2026, June 01). Guideline Development Group for Therapeutics for Ebola Virus Disease Therapeutics for Ebola Virus Disease. Available online: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/dcf2051a-394e-4bbd-8277-7eec0187fc18\/content."},{"key":"ref_50","unstructured":"WHO (2026, May 07). Strategic Advisory Group of Experts on Immunization Extraordinary Meeting of the Strategic Advisory Group of Experts on Immunization on Ebola Vaccination, May 2024: Conclusions and Recommendations. Available online: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/e63242a8-463c-4533-a062-b8be790400c2\/content."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa1904387","article-title":"Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination","volume":"391","author":"Muyembe","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"eadq2496","DOI":"10.1126\/scitranslmed.adq2496","article-title":"Ebola Virus Vaccination Elicits Ebola Virus\u2013Specific Immune Responses without Substantial Cross-Reactivity to Other Filoviruses","volume":"17","author":"Mdluli","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"ref_54","unstructured":"(2025). Sudan Virus Disease\u2014Uganda, World Health Organization. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON566."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Fletcher, P., O\u2019Donnell, K.L., Feldmann, F., Rhoderick, J.F., Clancy, C.S., Prator, C.A., Smith, B.J., Gunn, B.M., Feldmann, H., and Marzi, A. (2025). Single-Dose VSV-Sudan Virus Vaccine Protects from Lethal Sudan Virus Infection within One Week: A Challenge Study in Macaques: VSV-SUDV but Not VSV-EBOV Protects NHPs from Sudan Virus Disease. bioRxiv, bioRxiv:2025.03.26.645555.","DOI":"10.1101\/2025.03.26.645555"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Bockstal, V., Shukarev, G., McLean, C., Goldstein, N., Bart, S., Gaddah, A., Anumenden, D., Stoop, J.N., Marit de Groot, A., and Pau, M.G. (2022). First-in-Human Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules: A Randomized, Controlled Study. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0274906"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"eadk6176","DOI":"10.1126\/science.adk6176","article-title":"Oral Administration of Obeldesivir Protects Nonhuman Primates against Sudan Ebolavirus","volume":"383","author":"Cross","year":"2024","journal-title":"Science"},{"key":"ref_58","unstructured":"Malkevich, N., Morrow, G., Zaric, M., Meller, G., Talasila, S., Choi, Y., Peregrina, K., Wilson, A., Zhuo, L., and Postler, T. (2025, June 01). Preclinical Immunogenicity and Efficacy of a Vesicular Stomatitis Virus-Based Sudan Virus Vaccine and an Update on Its Performance in a Phase 1 Clinical Trial. Available online: https:\/\/www.iavi.org\/wp-content\/uploads\/2025\/02\/Preclinical-immunogenicity-and-efficacy-of-VSV-based-Sudan-virus-vaccine.pdf."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"101022","DOI":"10.1016\/j.lanmic.2024.101022","article-title":"Safety and Immunogenicity of a Bivalent Ebola Virus and Sudan Virus ChAdOx1 Vectored Vaccine in Adults in the UK: An Open-Label, Non-Randomised, First-in-Human, Phase 1 Clinical Trial","volume":"6","author":"Jenkin","year":"2025","journal-title":"Lancet Microbe"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1038\/s41467-025-59560-1","article-title":"Single-Dose Replicon RNA Sudan Virus Vaccine Uniformly Protects Female Guinea Pigs from Disease","volume":"16","author":"Anhalt","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/S2666-5247(23)00001-0","article-title":"Species-Specific Immunogenicity and Protective Efficacy of a Vesicular Stomatitis Virus-Based Sudan Virus Vaccine: A Challenge Study in Macaques","volume":"4","author":"Marzi","year":"2023","journal-title":"Lancet Microbe"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"eadw0659","DOI":"10.1126\/sciadv.adw0659","article-title":"The Oral Drug Obeldesivir Protects Nonhuman Primates against Lethal Ebola Virus Infection","volume":"11","author":"Woolsey","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"101110","DOI":"10.1016\/j.lanmic.2025.101110","article-title":"Uganda Launches Vaccine Trial for Sudan Virus Disease","volume":"6","author":"Adepoju","year":"2025","journal-title":"Lancet Microbe"},{"key":"ref_64","unstructured":"Kirenga, B.J. (2025, December 01). Solidarity\/Tokomeza Ebola Trial (TOKOMEZA), Available online: https:\/\/clinicaltrials.gov\/study\/NCT05909358."},{"key":"ref_65","unstructured":"IAVI (2025, December 01). Sudan Virus Vaccine Development Program. Available online: https:\/\/www.iavi.org\/wp-content\/uploads\/2025\/09\/iavi_fact_sheet_sudv.pdf."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13063-025-08805-x","article-title":"Leveraging an epidemic to establish vaccine clinical trial capacity in a low resource setting: The Ugandan experience","volume":"24","author":"Muttamba","year":"2025","journal-title":"Trials"},{"key":"ref_67","first-page":"432","article-title":"Severe Long-Term Clinical Sequelae among Sudan Ebolavirus Disease Survivors 2 Years Post-Infection","volume":"23","author":"Muwonge","year":"2025","journal-title":"Res. Sq."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kaweesa, R.E., Katende, J.S., Odoch, G., Ntabadde, A.D., Wayesu, R.R., Mukisa, D., Ejou, P., on Behalf of the FiloStudy Team, Kaleebu, P., and Serwanga, J. (2025). Two Decades Later: Long-Term Multisystem Sequelae and Subclinical Organ Dysfunction in Sudan Ebola Virus (SUDV) Survivors of the 2000 Outbreak. Viruses, 17.","DOI":"10.3390\/v17111410"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3201\/eid3102.240983","article-title":"Sudan Virus Persistence in Immune-Privileged Organs of Nonhuman Primate Survivors","volume":"31","author":"Beavis","year":"2025","journal-title":"Emerg. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/d41591-025-00012-0","article-title":"Sudan Ebola virus disease outbreak in Uganda\u2014A role for cryptic transmission?","volume":"31","author":"Bosa","year":"2025","journal-title":"Nat. Med."},{"key":"ref_71","unstructured":"World Health Organization (2026). Ebola Disease Caused by Bundibugyo Virus, Democratic Republic of the Congo & Uganda, World Health Organization. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2026-DON602."},{"key":"ref_72","unstructured":"World Health Organization (2026). Ebola Disease Caused by Bundibugyo Virus\u2014Democratic Republic of the Congo, World Health Organization. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2026-DON603."},{"key":"ref_73","unstructured":"World Health Organization (2026). Experts Convened by WHO Advise on Candidate Treatments and Vaccines for Ebola Disease Caused by Bundibugyo Virus, World Health Organization. Available online: https:\/\/www.who.int\/news\/item\/28-05-2026-experts-convened-by-who-advise-on-candidate-treatments-and-vaccines-for-ebola-disease-caused-by-bundibugyo-virus."},{"key":"ref_74","unstructured":"World Health Organization Daily Epidemiological Update on Acute Public Health Events: Ebola Disease (Bundibugyo Virus), World Health Organization. Available online: https:\/\/www.who.int\/emergencies\/alert-and-response."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/20477724.2020.1748965","article-title":"Chikungunya Fever in Africa: A Systematic Review","volume":"114","author":"Russo","year":"2020","journal-title":"Pathog. Glob. Health"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Bettis, A.A., Jackson, M.L., Yoon, I.-K., Breugelmans, J.G., Goios, A., Gubler, D.J., and Powers, A.M. (2022). The Global Epidemiology of Chikungunya from 1999 to 2020: A Systematic Literature Review to Inform the Development and Introduction of Vaccines. PLoS Neglected Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010069"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jiw391","article-title":"Chikungunya: Its History in Africa and Asia and Its Spread to New Regions in 2013-2014","volume":"214","author":"Zeller","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/22221751.2018.1559708","article-title":"Chikungunya Virus in Asia\u2014Pacific: A Systematic Review","volume":"8","author":"Stassen","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2015.04.016","article-title":"Chikungunya: Evolutionary History and Recent Epidemic Spread","volume":"120","author":"Weaver","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14745\/ccdr.v40i02a01","article-title":"Chikungunya Outbreak in the Caribbean 2013-2014","volume":"40","author":"Deilgat","year":"2014","journal-title":"Can. Commun. Dis. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14745\/ccdr.v41i01a01","article-title":"Travel-Related Chikungunya Cases in Canada, 2014","volume":"41","author":"Drebot","year":"2015","journal-title":"Can. Commun. Dis. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Faria, N.R., Louren\u00e7o, J., de Cerqueira, E.M., de Lima, M.M., Pybus, O., and Alcantara, L.C.J. (2016). Epidemiology of Chikungunya Virus in Bahia, Brazil, 2014-2015 ecurrents.outbreaks.c97507e3e48efb946401755d468c28b2. PLoS Curr., 8.","DOI":"10.1371\/currents.outbreaks.c97507e3e48efb946401755d468c28b2"},{"key":"ref_83","unstructured":"World Health Organization (2025, October 28). Chikungunya Virus Disease- Global Situation. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON581."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S1473-3099(24)00357-8","article-title":"Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: A single-arm, multicentre, phase 3b study","volume":"24","author":"McMahon","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","article-title":"Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: A double-blind, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"401","author":"Schneider","year":"2023","journal-title":"Lancet"},{"key":"ref_86","unstructured":"Kaslow, D. (2023). Accelerated BLA Approval\u2013IXCHIQ, U.S. Food and Drug Administration."},{"key":"ref_87","unstructured":"Health Canada (2025, October 17). Regulatory Decision Summary for IXCHIQ. Available online: https:\/\/dhpp.hpfb-dgpsa.ca\/review-documents\/resource\/RDS1719926004455."},{"key":"ref_88","unstructured":"European Commission (2025, October 17). Commission Authorises Chikungunya Vaccine and Funds New Mosquito Eradication Programme. Available online: https:\/\/ec.europa.eu\/commission\/presscorner\/api\/files\/document\/print\/en\/ip_24_3502\/IP_24_3502_EN.pdf."},{"key":"ref_89","unstructured":"Hills, S. (2025). Surveillance for Adverse Events Following Use of Live Attenuated Chikungunya Vaccine and Its Use among Travelers. Proceedings of the Advisory Committee on Immunization Practices Meeting, U.S. Centers for Disease Control and Prevention (CDC)."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2500543","DOI":"10.2807\/1560-7917.ES.2025.30.32.2500543","article-title":"Surveillance for Adverse Events Following Use of Live Attenuated Chikungunya Vaccine, United States, 2024, and the Associated Public Health Response in 2024 and 2025","volume":"30","author":"Hills","year":"2025","journal-title":"Eurosurveillance"},{"key":"ref_91","unstructured":"EMA (2026, January 15). EMA Starts Review of Ixchiq (Live Attenuated Chikungunya Vaccine). Available online: https:\/\/www.ema.europa.eu\/en\/news\/ema-starts-review-ixchiq-live-attenuated-chikungunya-vaccine."},{"key":"ref_92","unstructured":"US Food and Drug Administration (2025, October 17). FDA and CDC Recommend Pause in Use of Ixchiq (Chikungunya Vaccine, Live) in Individuals 60 Years of Age and Older While Postmarketing Safety Reports Are Investigated, Available online: https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/fda-and-cdc-recommend-pause-use-ixchiq-chikungunya-vaccine-live-individuals-60-years-age-and-older."},{"key":"ref_93","unstructured":"European Medicines Agency (2025, October 17). Ixchiq: Temporary Restriction on Vaccinating People 65 Years and Older to Be Lifted. Available online: https:\/\/www.ema.europa.eu\/en\/news\/ixchiq-temporary-restriction-vaccinating-people-65-years-older-be-lifted."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"128491","DOI":"10.1016\/j.vaccine.2026.128491","article-title":"Post-marketing safety evaluation of the live-attenuated chikungunya vaccine (IXCHIQ)","volume":"79","author":"Vondeling","year":"2026","journal-title":"Vaccine"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"ofaf550","DOI":"10.1093\/ofid\/ofaf550","article-title":"Fatal Adverse Event After VLA1553 Chikungunya Vaccination in an Elderly Patient: A Case Report from Reunion Island","volume":"12","author":"Mosnier","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e2532212123","DOI":"10.1073\/pnas.2532212123","article-title":"Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis","volume":"123","author":"Gervais","year":"2026","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1473-3099(25)00552-3","article-title":"More Data Needed on the FDA\u2019s Decision to Suspend Ixchiq","volume":"25","author":"Diseases","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Kasturiratne, A., Wickremasinghe, A.R., de Silva, N., Gunawardena, N.K., Pathmeswaran, A., Premaratna, R., Savioli, L., Lalloo, D.G., and de Silva, H.J. (2008). The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and Deaths. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050218"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40409-017-0127-6","article-title":"Snakebite Envenomation Turns Again into a Neglected Tropical Disease!","volume":"23","author":"Chippaux","year":"2017","journal-title":"J. Venom. Anim. Toxins Trop. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1016\/j.cell.2025.03.050","article-title":"Snake Venom Protection by a Cocktail of Varespladib and Broadly Neutralizing Human Antibodies","volume":"88","author":"Glanville","year":"2025","journal-title":"Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(23)00002-8","article-title":"Clinical aspects of snakebite envenoming and its treatment in low-resource settings","volume":"401","author":"Warrell","year":"2023","journal-title":"Lancet"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"17063","DOI":"10.1038\/nrdp.2017.63","article-title":"Snakebite Envenoming","volume":"3","author":"Calvete","year":"2017","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_103","unstructured":"European Centers for Disease Control and Prevention (2026, June 01). Seasonal Surveillance of Crimean-Congo Haemorrhagic Fever (CCHF) in the EU\/EEA, Weekly Report. Week 41. Available online: https:\/\/www.ecdc.europa.eu\/en\/crimean-congo-haemorrhagic-fever\/surveillance-and-updates\/seasonal."},{"key":"ref_104","unstructured":"World Health Organization (2026, June 01). Crimean Congo Hemorrhagic Fever. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/crimean-congo-haemorrhagic-fever."}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/18\/3\/60\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:52:18Z","timestamp":1782535938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/18\/3\/60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":104,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["idr18030060"],"URL":"https:\/\/doi.org\/10.3390\/idr18030060","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]}}}